No Data
No Data
Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%
Cannabis-focused company Melodiol Global Health's (ASX:ME1) shares surged 50% on Thursday following the launch of several products by its Canadian subsidiary Mernova, as well as new purchase orders. M
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic
Melodiol Global Health (ASX:ME1), through its subsidiary Health House Australia, is set to launch its medicinal cannabis clinic called the Health House Wellness Clinic in the second quarter of 2024, a
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million
Melodiol Global Health (ASX:ME1) has posted unaudited revenues of AU$3.1 million through February and ongoing total unaudited group revenue from all operations of AU$21.6 million in the 2023 financial
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces
Melodiol Global Health's (ASX:ME1) Canadian subsidiary Mernova Medicinal reached agreements with six provincial governments in Canada to add more cannabis-related products during the first fiscal quar
Melodial's Unit Logs AU$1 Million Revenues in January
Melodiol Global Health (ASX:ME1) said its unit Health House International reported a revenue of AU$1 million in January. The revenue was generated from the medicinal cannabis company's established Aus
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October
Melodiol Global Health (ASX:ME1) said Canadian subsidiary Mernova Medicinal has secured several purchase orders to "underpin" fiscal fourth-quarter revenue. The firm also said that the unit logged rec
No Data